Physician profile
Marlie Similien
NPI 1932711728
$1,402.32
in general payments reported to CMS, 2019-2025
14 companies · $264 in 2025
The $264 reported for 2025 was more than what 87% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $481 · 2023: $382 · 2024: $72.05 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $332.97 | 2021-2024 | |
| Coopersurgical, INC. | $199.52 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $139.09 | 2022-2023 | Nexplanon |
| Exact Sciences Corporation | $138.86 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Myovant Sciences INC. | $126.21 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.00 | 2021-2025 | |
| Evofem Biosciences, INC. | $85.94 | 2022-2025 | Solosec, Phexx, Phexxi |
| Aspira Women'S Health INC | $80.00 | 2023 | Ova1 |
| Hologic Sales and Service, LLC | $72.22 | 2025 | Thinprep 2000 Processor, Aptima |
| Scynexis, INC. | $53.72 | 2022 | |
| Biogen, INC. | $29.50 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $23.20 | 2023 | Myfembree |
| Millicent US INC | $18.73 | 2025 | Femlyv |
| Pacira Pharmaceuticals Incorporated | $13.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlie Similien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.